Human Health and Exposure Monitoring Teams

The current 2024 research portfolio under the health and exposure programme looks as follows:

• B24: Modeling exposure and biodistribution of microplastic particles in the human body
  Principal investigator: Albert Koelmans, Wageningen University, NL
• C5: Integrating Multiple Molecular-level Data Streams to understand (a) range of normal adaptation vs
  pathology and (b) molecular generated gene expression changes and persistence over time.
  Principal investigator: Jörg Hackermüller, Helmholtz Centre for Environmental Research (UFZ), DE
• C8: MATCHING – MetAbolomics ring-Trial for CHemical groupING
  Principal investigator: Mark Viant, University of Birmingham, UK
• C10: A Tiered Strategy to Assess Microplastic Inhalation
  Principal inverstigator: Tanja Hansen, ITEM Fraunhofer, DE  
• EMSG59.2: Developing a quantitative AOP for liver-mediated thyroid modulation after prenatal exposure to a xenobiotic compound in the rat. Principal investigator: Aldert Piersma, RIVM, NL

For more information on the LRI, visit their website http://www.cefic-lri.org.